Research has attempted to identify biomarkers of aging that are predictive of longevity and specific age-related changes during animal life span. Tail tendon break time (TTBT), one presumed biomarker, measures collagen cross-linking, known to increase with age. Significant differences in the rate of increase of TTBT with age have been reported between mouse strains and animal species. We measured both TTBT and longevity in C57BL/6J, DBA/2J, and 23 recombinant inbred (RI) strains (B×D RIs), with TTBT measured at 200, 500, and 800 days of age. Longevity demonstrated considerable variability among these strains (116-951 days). TTBT, also highly variable, increased significantly with age in both sexes and all genotypes. Neither TTBT nor its rate of change correlated significantly with life span. There were suggestive trends for rate of TTBT change to correlate with male longevity and strain longevity to correlate with female TTBT. We conclude that for the range of genetic variation found among these mouse genotypes, TTBT cannot be considered a robust biomarker of longevity.
T HE practical value of developing reliable indicators of biological, as contrasted to chronological, age has been appreciated for more than two decades (1) . The concept of biological age implicitly assumes that there exist better indicators of future life expectancy and/or generalized health than chronological age itself (2) . The recent discovery that physical appearance as revealed by a simple passport-type photograph can be used to predict which member of an elderly twin pair is likely to die first supports the idea that such biomarkers exist, at least for humans, even if they might require a sophisticated pattern recognition system like the human brain (3) . In animals, probably the most compelling evidence that biological age, separable from chronological age, exists is that many (but not all) degenerative processes in laboratory rodents are retarded by dietary restriction (4) (5) (6) . Thus, animals of the same chronological age differ substantially in their degree of physiological degeneration depending only on their dietary history (7) .
Such potential indicators, which have been termed "biomarkers of aging," would clearly be valuable for assessing the possible efficacy of interventional therapeutics in humans. They would also hasten the pace of aging research in animals by providing a much quicker readout on the impact of putative senescence-retarding therapies than waiting for all experimental animals to die so that the impact on longevity might be assessed (8, 9) . Because of these acknowledged advantages, the National Institute on Aging in collaboration with the National Center for Toxicological Research and a host of independent scientists devoted a 10-year effort to the identification of such biomarkers (9) . Unfortunately, no robust biomarkers were uncovered during this effort.
The specific features that would make biomarkers of aging most useful have been variously discussed and defined over time (10) (11) (12) . Among these features are (1) the rate of change with age should reflect the rate of aging; (2) some basic process should be monitored; (3) markers should be nonlethal, noninvasive, or minimally intrusive; (4) they should be highly reproducible; (5) they should reflect physiological age; (6) they should change substantially over a short period relative to the organism's life span; (7) they should be crucial to the maintenance of health; (8) they should be measurable in a variety of species; (9) they should serve as a better predictor of life span than chronological age; and (10) they should be insensitive to previous measurement effects (11) . Several of these features are redundant, and virtually, none has lacked controversy with the possible exception of 1 and 9. Importantly, to date, no generally agreed upon biomarkers have been identified.
Long-lived structural proteins such as collagen and lens crystallins have been reported to "age." That is, they change biochemically in a progressive unidirectional fashion with the age of the animal (13) . In particular, collagen, which forms much of the structure and support for the vertebrate body, progressively "yellows" with age, displaying reduced solubility and digestibility. These changes are thought to be primarily due to nonenzymatic cross-links among and within collagen molecules as a consequence of Maillard reaction chemistry and the consequent formation of advanced glycation end-products (14, 15) . Such changes with age occur in collagen molecules in a range of tissues and likely contribute to tissue dysfunction (16) (17) (18) .
Tendons are composed almost entirely of collagen fibers and thus "age" chemically. One assay that has found repeated use as an indicator of biological age in mammals is tail tendon break time (TTBT) (17) (18) (19) (20) (21) (22) (23) . This simple assay, which though somewhat invasive can be performed serially at least four times in the same individual animal because mammals typically have four separate tendon bundles, measures the resistance of tail tendon fibers to degradation by concentrated urea (17) . TTBT typically increases with age, presumably due to increasing numbers of nonenzymatic cross-links in the collagen molecules of which the tendon is composed (15) . Thus, fibers with greater breaking time are considered to be more aged compared with those displaying shorter breaking times.
TTBT has been most thoroughly investigated as a potential biomarker of aging in mice, although results to date have been mixed. For instance, consistent with TTBT as an aging biomarker, fiber break times increased with age twice as fast in wild-derived female house mice (Mus musculus) compared with female white-footed mice (Peromyscus leucopus), which live twice as long (24) . On the other hand, the rate of TTBT change did not differ among males of these two species, even though the same longevity difference obtains. Two other independent studies also provide some support for the idea of TTBT as aging biomarker, each finding greater TTBTs at the same chronological age in shorter lived DBA/2 compared with longer lived C57BL/6 mice (18, 25) . Also consistent with biomarker criteria, longlived Snell dwarf mice displayed a slower rate of increase in TTBT than shorter lived littermate controls (22) , and shortlived ob/ob mice have accelerated tail tendon aging relative to nonobese controls (6) . Perhaps, most supportive of TTBT as an aging biomarker is the observation that dietary restriction significantly retards collagen aging and extends life in multiple mouse and rat genotypes (4) (5) (6) 15) .
Less supportive of TTBT's role as a putative biomarker as defined, two mouse strains (CBA and C57BL/6) with similar mean life spans displayed substantial differences in the rate of change in TTBT with age. Tail tendons aged substantially faster in CBA mice, which although not shorter lived in early reports are known to exhibit more rapid reproductive (ie, ovulatory) senescence than C57BL/6 mice (24). Interestingly, a more recent study of the longevity of these two strains found CBA to be substantially shorter lived than C57BL/6 (26), supporting TTBT as a reasonable biomarker. More generally, Harrison and colleagues found no correlation between the rate of change in tendon aging and mean longevity among both sexes of three inbred strains and two F1 hybrids between strains (17) . It should be noted that this lack of correlation was among mouse genotypes that did not differ dramatically in mean longevity (range: 791-925 days), so potentially, TTBT might be useful at distinguishing mice over a wider range of longevities. Heller and McClearn (1992) also found that TTBT values for F 1 crosses between C57BL/6 and DBA/2 strains fell between the progenitor strains even though this F 1 is longer lived than either progenitor strain (27) . Also, in a heterogeneous stock of mice, TTBT was not predictive of individual longevity (12) .
Even though TTBT has been shown repeatedly to increase with age, the relationship of its absolute values or age-related rate of change to mouse longevity remains unclear. In this study, which was part of a larger investigation of potential aging biomarkers from a variety of behavioral and physiological domains, we examine how well TTBT associates with longevity across 25 mouse genotypes, C57BL/6J (hereafter B6), DBA/2J (hereafter D2), and 23 recombinant inbred (RI) lines created from those two parental strains. As such, this is the largest exploration of the potential utility of TTBT as a biomarker in mice to date.
Materials and Methods

Animals and Husbandry
All mouse strains tested, B6, D2, and the 23 RI strains derived from the two progenitor strains, were originally obtained from The Jackson Laboratory. Mice actually used in the experiment were born and housed in a barrier facility maintained by the Center for Developmental and Health Genetics at the Pennsylvania State University. The 23 B×D RI strains included strain numbers 2, 6, 8, 11, 12, 13, 14, 16, 19, 22, 24, 27, 28, 29, 30, 31, 32, 33, 34, 38, 39, 40, and 42. TTBT was measured after mice were sacrificed at three ages (200, 500, and 800 days) spanning a large fraction of the total life span in all 25 genotypes. Some strains did not survive long enough to be measured at all three ages. For instance, strain 13 (median longevity 116 and 158 days in males and females, respectively) did not survive long enough even to be assayed at 500 days of age much less at 800 days. Ultimately, the TTBT assay included 544 mice of 25 genotypes at 200 days (mean of 10.9 mice per sex per strain), 433 mice from 24 genotypes at 500 days (mean of 9.0 mice per sex per strain), and 263 mice of 20 genotypes at 800 days of age (6.3 mice per sex per strain).
The longevity portion of the study included 12 males and 12 females from each strain for a total of 294 males and 291 females, and age at death of each individual was recorded. Occasionally, however, individual animals were lost to accidents. No sex/strain survival group contained fewer than 10 animals. In total, longevity of 294 males and 291 females was determined. These animals were maintained without experimental interventions until natural death or standard moribundity criteria were met.
Mice of the same litter and sex were housed four per microisolator cage upon weaning. All mice were maintained on a schedule of 12-hour light/dark cycle at a temperature of 21°C ± 2°C with approximately 50% humidity. Mice were fed autoclaved Purina Laboratory Rodent Chow Diet #5010 and water ad libitum. All procedures complied with and were approved by the Pennsylvania State University Institutional Animal Care and Use Committee.
Collagen Denaturation Assay
Mice from each age group were sacrificed by cervical dislocation at ~200/500/800 days of age. The tails were collected prior to further dissection and harvesting of tissues for additional experimental assays.
The protocol for collagen fiber removal was a modified version of that reported by . Dorsal tendons were removed from the tail, and individual collagen fibers were separated. For each mouse, three fibers of intermediate thickness were chosen. Using 5-0 surgical silk, each fiber was attached to a 2.0 g weight and suspended in a 125-mL Erlenmeyer flask filled with a 7 M urea solution to denature the collagen fibers at 45°C ± 0.1°C. Fiber break times were measured by recording time of initial suspension until the fiber broke, with the weight dropping to the bottom of the flask.
Statistics
A mean TTBT of the three fiber break times was used to represent each individual. Log transformations were calculated on the TTBT data to linearize the increase in TTBT with age. Rates of change were calculated to determine change scores of TTBT from 200 to 500 days of age and 500 to 800 days of age. Lastly, correlations were calculated to determine whether TTBT values were significantly correlated with median longevity (SPSS 16).
Results
Longevity
Not surprisingly, there was considerable variability in longevity among the RI lines. Mean longevity ranged from a low of 116 days in B×D13 males to 951 days B×D19 males. Thus, as expected, some RI lines had life spans that were substantially below, others substantially above, either of the parental strains ( Figure 1 ). There was also substantial variation in within-strain sex difference in longevity. For instance, median longevity of B×D2 males was 66% greater than females of the same strain, whereas in B×D16, there was virtually no longevity difference between the sexes and in B×D28, females lived 36% longer than males. There is at least as much variability in longevity as that observed among 31 inbred laboratory mouse strains deliberately chosen for their genetic diversity (26) . Thus, ample opportunity existed to determine a putative relationship between TTBT and strain longevity.
TTBT and Strain Longevity
TTBT was also highly variable among strains. TTBT increased significantly with age in both sexes, both progenitors, and all RI strains, although the rate of change varied among strains as expected. The rate of change in tendon breaking time accelerated with age in both sexes and all strains as well ( Figure 2) . Thus, collagen "aged" in the traditional sense as measured by TTBT in all strains.
The B×D22 strain was a statistical outlier, clearly having unusual collagen properties, with far greater TTBT values than any other strain. According to the TTBT assay, young (200 days) B×D22 animals had collagen as "aged" as 600+-day-old animals of most other strains. However, we do not know whether this resistance to breaking was due to increased collagen cross-linking or some other property of the tendon. It may be worth noting that the age-related rate of increase in break time for B×D22 animals does not differ dramatically compared with that occurring at later ages in a number of other strains (Figure 2) . Because of these anomalies, the B×D22 strain is deleted from the following analyses. Note, however, that even with these unusual collagen properties, the longevity of the B×D22 animals is not unusual compared with other strains, suggesting that normal collagen properties are not critical for the maintenance of health in laboratory mice.
As in previous reports, we also found that shorter lived D2 mice had greater TTBTs than B6 mice at a given age and also a more rapid increase over the latter part of the life span (Figure 2 ). However considering all strains together, TTBT at any of our three ages tested failed to significantly correlate with strain life span (Figures 3 and 4) . Statistical significance was approached (p = .076) for 200-day TTBT in females only, but this marginal significance disappeared when the exceptionally short-lived (median <500 days) strains were removed from the analysis. Interestingly, if females are grouped into short-lived (<600 day), mediumlived (600-800 days), and long-lived (>800 days) strains, the 200-day TTBT results do indicate that the shortest lived female strains have statistically lower TTBT than the longest lived strains (two-way analysis of variance, p = .021 and Student-Newman-Keuls post hoc test, p <.05). We note that this marginally significant result is in the opposite direction from numerous previous findings in which greater TTBT associated with shorter life. Also, significance was not observed in a similar analysis of males. Neither logarithmic transformation of the data nor the use of mean rather than median longevity affected these results.
If absolute TTBT tracks unevenly with strain longevity, is it possible that the rate of change in TTBT would do better? As with the absolute TTBT values, there are no clearly significant and only one marginally significant results. The rate of increase in TTBT between 500 and 800 days marginally correlated with median longevity in males only (r = .406, p = .060). All other rates of change (either between 200 and 500 or 500 and 800 days) failed to come close to statistically correlated with median or mean strain longevity in either sex whether the data were log transformed (200-500 days: females: r = -−.084, p = .696; males: r = −.053, p = .807; 500-800 days: females: r = .022, p = .926) or not or whether unusually short-lived strains were removed from the analysis or not ( Figure 5 ).
In sum, these findings indicate that although TTBT reliably increased with age in all strains and sexes investigated, neither absolute TTBT values nor their rate of change in those values robustly correlated with strain longevity. So at least for the range of genetic variation found among these mouse genotypes, TTBT cannot be considered a useful biomarker of aging when examining longevity.
Discussion
Previous researchers had convincingly shown that TTBT in multiple strains, stocks, and species of mammals increased with age and that the rate of increase was retarded by longevity-enhancing dietary restriction (4, 5) . In this study, we found that TTBT increased dramatically with age in all 25 inbred mouse strains examined. Thus, collagen itself aged. Furthermore, as previously reported, TTBTs in the short-lived D2 mouse strain were greater than in the longer lived B6 strain. However, there was no robust statistical relationship between any aspect of TTBT and strain Figure 4 . Natural log-transformed mean tail tendon break time at 500 and 800 days of age versus strain longevity. Log transformation makes numerical trends more easily seen. None of these relationships approach statistical significance (500 days: p = .98 for females, p = .17 for males and 800 days: p = .36 for females, p = .098 for males). The same holds true for the nontransformed data. longevity in this series of 23 RI strains and the two parental strains from which they were derived. TTBT at 200 days of age was marginally associated (p = .076) with longevity in females only and could be made significant by binning the data in certain ways to indicate that females in the five shortest lived strains had paradoxically "younger" collagen than in the five longest lived strains. Perhaps, low TTBT values at young ages have some value for indicating of poor female mouse health. In males, the rate of change in TTBT with age between 500 and 800 days was marginally correlated with strain longevity. But this was not observed in females nor in male TTBT between 200 and 500 days.
Although our study measured TTBT only in inbred laboratory strains, which are homozygous at all loci and thus possess a variety of quirks, our results are generally consistent with a previous study in which TTBT failed to predict remaining life span among genetically heterogeneous laboratory mice (12) . Thus, although TTBT satisfies many criteria of an aging biomarker such as being highly reproducible, minimally invasive, insensitive to previous measurement effects, changing substantially over a short period relative to the organism's life span (in unpublished work, we found significant changes within as little as 60 days), and being altered in the expected direction by dietary restriction, it does not robustly fulfill the primary criterion of predicting remaining life span-at least for mice of a B6×D2 lineage, therefore making it a biomarker of collagen aging. We emphasize that all our mice were ad-lib fed and that these data do not bear on how TTBT might be affected by the longevity impact of dietary restriction.
If we assume that life span itself reflects the rate of aging, then TTBT also fails the criterion of its rate of change reflecting the rate of aging, except in males, only in one age interval was there even marginal significance. Furthermore, as one strain (B×D22) with highly aberrant collagen properties exhibited normal longevity, collagen properties per se cannot be said to be crucial to the maintenance of a mouse's health.
Previous support for TTBT as a reliable biomarker came from five types of evidence: (a) comparison of a long-lived (P. leucopus) and short-lived (M. musculus) mouse species (24); (b) comparison of a reasonably long-lived mouse strain (B6) compared with a shorter lived strain (D2), which had been genetically separated for a century (18, 25, 28) ; (c) comparison of a long-lived Snell dwarf mouse mutant with littermate controls (22) ; (d) comparison of a variety of mouse and rat genotypes when fully fed compared with calorically restricted; and (e) comparison between two wild opossum populations, a shorter lived mainland population and a longer lived island population (21) .
To what might these previous observations, consistent with longevity differences, be attributed? One thing might be temperature. An earlier report noted that TTBT is affected by temperature, with lower temperatures in the more distal part of a mouse's tail, leading to a reduced rate of collagen aging compared with the base of the tail (17) . So it is tempting to posit that some of these results may be due to differences in body temperature. In a long thin appendage like the tail, ambient temperature might also be a factor. Consistent with this interpretation, dwarf mice and calorierestricted rodents both display lower body temperatures than normal size fully fed animals (4, 29, 30) . Peromyscus leucopus undergoes daily torpor in the laboratory, generally under conditions of short photoperiod, reduced food, or cold temperature; however, they can enter daily torpor under normal laboratory conditions as well (31) (32) (33) . So it is conceivable that collagen aging is retarded in female P. leucopus relative to female laboratory mice because of long-term differences in overall body temperature. However, this would not explain why there was no difference in collagen aging seen in males of the two species. It is also conceivable that insular opossums experience lower mean annual ambient temperature than mainland opossums. Generally, surrounding seawater has a moderating effect on the ambient temperature of islands, but the actual microclimates that opossums experience in the two locations are unknown. There is no reported difference, however, in body temperature between B6 and D2 mice, although detailed 24-hour measurements have not been reported (34) .
Collagen cross-linking is generally thought to occur because of nonenzymatic amino-carbonyl reactions of sugars with collagen molecules called the browning or the Maillard reaction. Because this reaction involves oxidation, the end-products are often called collectively glycoxidation products (15) . As these reactions are nonenzymatic, their rate should be affected not only by temperature but also by the concentration of reactants. Thus, serum glucose and protein oxidation status ought to affect the rate of crosslinking. Indeed, age-related collagen cross-linking is known to be accelerated by uncontrolled diabetes (14) and in the leptin-deficient ob/ob mouse model of type II diabetes (6) . Consistent with this hypothesis, both calorie-restricted and Snell dwarf mice have reduced serum glucose concentrations as well as reduced oxidative damage to tissues relative to controls (35, 36) . D2 mice have not, however, been reported to exhibit higher serum glucose concentrations than B6 mice (Mouse Phenome Database, http://www.jax.org/). Relative levels of protein oxidation in these two strains have not been reported nor have they for the two opossum populations.
How do these results compare with those for other putative biomarkers in mice? As has become evident in recent years, body size is inversely associated with longevity across a substantial range of mouse genotypes (37) . Among genetically heterogeneous mice derived from laboratory ancestors, body size was a significant predictor of individual longevity from as early as 2 months of age (38) . Smaller body size is also found of course in calorically restricted mice. On the other hand, among calorically restricted mice, larger mice have been reported to live longer than smaller mice (39) . In addition, in a wild-derived mouse population fed a standard laboratory diet, no relationship between individual body mass and longevity was observed (40) .
T-cell subsets have also been reported to predict individual longevity better than chronological age in genetically heterogeneous laboratory mice, although the correlation between various subset measurements and longevity explains less than 20% of the variation (41) . Additionally, dwarf mouse mutants have "younger" looking T-cell subsets than littermate controls (22, 38) . As with a number of other putative biomarkers, these results need to be replicated and extended to other mouse genotypes and other health-extending treatments besides dwarfing mutations before receiving general acceptance.
In fruit flies, gene expression patterns have been correlated with aging rate, even as that rate was altered by temperature or longevity-conferring mutations (42) . Thus, biomarkers of aging may emerge from the detailed study of gene expression patterns. For instance, the expression of p16Ink4a and Arf increases with age in multiple tissues and that rate of increase is retarded by dietary restriction (43) . These patterns are consistent with those one would observe with a robust biomarker, although TTBT also satisfies these criteria even as it fails in other senses. Clearly, a wider range of longevity-altering treatments and genotypes needs to be investigated before any larger conclusions can be reached.
An intuitively satisfying idea is that DNA microarray expression profiles, because they represent hundreds or thousands of potentially independent traits, might prove particularly valuable in predicting future life span and health span. At present, such studies are in their infancy. However, a variety of statistical approaches have been employed to determine if, say, caloric restriction or drug treatments lead to a more "youthful" gene expression pattern. Although some promising results have begun to materialize from such an approach (44, 45) , results from across studies have been mixed (46) .
Given the earlier discussion, it may be worth revisiting how one might experimentally approach validating potential biomarkers in mice. Previously, biomarker validation has focused almost exclusively on correlations with changes in life span, particularly correlations with increased life span. It is worth noting that the rationale for viewing animal models with shortened life span with some suspicion is that life span can be shortened in many ways that have little or nothing to do with fundamental aging processes (47, 48) . This is not to suggest that informative "accelerated aging" models do not exist or cannot be developed but that short life span by itself is not useful for determining whether aging has been accelerated or not. Over most of the course of mammalian aging research, there was only one way to extend life-dietary restriction. Because most (but not all) of the changes attendant on dietary restriction were consistent with improved and extended health, assays that were altered in the expected direction by dietary restriction had a special claim on being taken seriously as potential biomarkers. These assays met a necessary but not sufficient condition of biomarker validation. The strongest case for a valid biomarker of aging would have been that it changed in the appropriate direction with dietary restriction and it predicted longevity better than age among genetically heterogeneous strains or individuals.
Today, there is a much richer experimental landscape for the development of aging biomarkers. We can now extend mouse life span in many ways, including by multiple types of genetic (49) , dietary (50) , and pharmacological manipulation (51, 52) . We also know of genotypes that are resistant to some of these treatments (53) and have identified mouse genotypes from natural populations that are long lived (54) and/or exhibit other signs of extended health (55) . It may further be noted that there is a conditionality about the evidential base for disqualifying a nominated biomarker. The burgeoning evidence on genetics and complex biological systems suggests that a marker phenotype that may be predictive on one genetic background may be minimized on another. Considerations of complexity also suggest that a marker without predictive solo value may be an active participant in an interactive multivariate scenario. Though comparing only inbred strains in this study, genetically heterogeneous stocks will be of value in exploring these possibilities. These resources, particularly in combination with emerging techniques for the assessment of mouse health (56) , offer manifold possibilities to determine whether there exist broadly useful aging biomarkers. The utility of such biomarkers has never been in doubt.
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